Shandong Sinobioway Biomedicine Co.Ltd(002581) : suggestive announcement on the judicial auction of the company's shares held by the largest shareholder

Securities code: Shandong Sinobioway Biomedicine Co.Ltd(002581) securities abbreviation: Shandong Sinobioway Biomedicine Co.Ltd(002581) Announcement No.: 2022020

Shandong Sinobioway Biomedicine Co.Ltd(002581)

Suggestive announcement on the judicial auction of the company's shares held by the largest shareholder

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without any false information

Records, misleading statements or material omissions.

Special tips:

Held by Beijing Beida Weiming bioengineering Group Co., Ltd., the largest shareholder of the company, accounting for the total share capital of the company

8.67% of the company's shares will be auctioned by judicial auction. If the largest shareholder holds 8.67% of the shares of the company in this auction

If the auction is successful, the company may have the risk of changing the largest shareholder and actual controller, and such risks may exist at the same time

The legal risk in the process of equity transfer, the risk of substantive transfer of control, and the risk of instability in the company's transition period

(including but not limited to the influence of unstable factors on the board of directors, management and employees of the company and its subsidiaries),

Investors should pay attention to investment risks.

1、 Basic information about the judicial auction of shareholders' shares

Shandong Sinobioway Biomedicine Co.Ltd(002581) (hereinafter referred to as "the company") learned through inquiry that Shenzhen

Futian District People's court will be from 10:00 on May 25, 2022 to 10:00 on May 26, 2022 (Extended)

(except) on the Taobao judicial auction network platform, the company's largest shareholder, Beijing Peking University unnamed biology, was publicly auctioned

The total shares of the company held by Engineering Group Co., Ltd. (hereinafter referred to as "unnamed group") are 57204000

Shares, accounting for 8.67% of the total share capital of the company.

The specific matters related to this share auction are as follows:

Whether it is holding the shares of this auction and whether the company it occupies is

Shareholder name shareholder or the first number of shares total share capital restricted shares starting date expiration date auctioneer reason major shareholder and its (share) proportion and restricted sales

Types of persons acting in concert

Beijing University Shenzhen

Unnamed creatures are 57204000, 74.84% and 8.67% are from Futian District judicial Engineering Group / 25 / 26 people's law ruling Co., Ltd

2、 Risk warning and its impact on the company

1. As of the disclosure date of this announcement, the unnamed group holds 76431020 shares of the company, accounting for 11.59% of the total shares of the company; 57204000 shares will be auctioned, accounting for 74.84% of the total shares of the company and 8.67% of the total share capital of the company.

2. Up to now, the judicial auction is still in the publicity stage, and the follow-up may involve auction, payment, equity change and transfer, and there is some uncertainty. The company will pay close attention to the follow-up progress of the matter and fulfill the obligation of information disclosure in time according to the progress.

If the shares held by the major shareholders of the company and the actual controlling shareholders of the company have been frozen at the same time in the process of the first judicial announcement, there is a risk of 3.67% of the shares held by the major shareholders of the company and the actual controlling shareholders of the company may be frozen at the same time For the instability risk of the company during the transition period (including but not limited to the influence of unstable factors of the board of directors, management and employees of the company and its subsidiaries), investors are reminded to pay attention to the investment risk. 4. The company solemnly reminds the majority of investors that the relevant information of the company is based on the media securities times and cninfo, which meet the requirements of the CSRC( http://www.cn.info.com.cn. )The relevant announcements disclosed on the website shall prevail. Please make rational decisions and pay attention to investment risks.

It is hereby announced.

Shandong Sinobioway Biomedicine Co.Ltd(002581) board of directors may 20, 2022

- Advertisment -